Sho Iketani

17PUBLICATIONS
72CO-AUTHORS
Molecular medicineInnate immunityMedical molecular engineering of nucleic acids and proteinsCheminformatics and quantitative structure-activity relationshipsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 19, 2026
Cross-resistance patterns in SARS-CoV-2 against 3CL protease inhibitors.

|Jan 27, 2025
Distinct CD8+ T-cell types Associated with COVID-19 Severity in Unvaccinated HLA-A2+ Patients.

Kazuya Masuda, Sho Iketani, Lihong Liu

|Jan 06, 2025
A multiplex method for rapidly identifying viral protease inhibitors.

Seo Jung Hong, Samuel J Resnick, Sho Iketani

|Jan 03, 2025
Development of small molecule non-covalent coronavirus 3CL protease inhibitors from DNA-encoded chemical library screening.

Hengrui Liu, Arie Zask, Farhad Forouhar

|Oct 23, 2023
Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike.

Qian Wang, Yicheng Guo, Liyuan Liu

|Sep 11, 2023
Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir.

Yinkai Duan, Hao Zhou, Xiang Liu

Pageof 3

Frequent Collaborators

11 joint publications

David D Ho

8 joint publications

Yaoxing Huang

7 joint publications

Manoj S Nair

6 joint publications

Yicheng Guo